| 2025-12-01 |
详情>>
内部人交易：
Spath John B.股份减少126.00股
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本16998.88万股
变动原因 ▼▲
- 原因：
- From June 30, 2025 to September 30, 2025
Equity-based compensation stock issuances
Purchase of treasury stock
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.65美元,归母净利润-2.92亿美元,同比去年增长-2354.44%
|
| 2025-11-05 |
财报披露：
美东时间 2025-11-05 盘后发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-1.1美元,归母净利润-1.96亿美元,同比去年增长-95.69%
|
| 2025-05-06 |
详情>>
业绩披露：
2025年一季报每股收益-0.05美元,归母净利润-986.8万美元,同比去年增长91.22%
|
| 2025-04-18 |
股东大会：
将于2025-05-29召开股东大会
会议内容 ▼▲
- 1.To elect to the Company’s Board of Directors the director nominees set forth in the accompanying Proxy Statement, each of whom will hold office for a one year term until the next annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal.
2.To approve, on a non-binding advisory basis, the Company’s Named Executive Officers’ compensation for the fiscal year ended December 31, 2024.
3.To approve, on a non-binding advisory basis, the frequency of future advisory votes on the Company’s Named Executive Officers’ compensation for every one year, every two years, every three years or stockholders may abstain from voting.
4.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025.
5.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益-0.44美元,归母净利润-7639.3万美元,同比去年增长-140.78%
|
| 2025-02-27 |
详情>>
业绩披露：
2022年年报每股收益4.63美元,归母净利润3.82亿美元,同比去年增长308.75%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.07美元,归母净利润-1188.5万美元,同比去年增长-111.72%
|
| 2024-11-12 |
详情>>
业绩披露：
2023年年报每股收益1.56美元,归母净利润1.87亿美元,同比去年增长-50.95%
|
| 2024-10-01 |
复牌提示：
2024-10-01 08:52:57 停牌，复牌日期 2024-10-01 09:12:02
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.59美元,归母净利润-1亿美元,同比去年增长-196.64%
|
| 2024-08-08 |
详情>>
业绩披露：
2023年中报每股收益0.90美元,归母净利润1.04亿美元,同比去年增长-19.55%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.71美元,归母净利润-1.12亿美元,同比去年增长-225.13%
|
| 2024-04-17 |
股东大会：
将于2024-05-23召开股东大会
会议内容 ▼▲
- 1.To elect to the Company’s Board of Directors the three Class III director nominees, set forth in the accompanying Proxy Statement, each of whom will hold office until the next annual meeting of stockholders and until his or her successor is duly elected and qualified or until his or her earlier death, resignation or removal.
2.To approve, on a non-binding advisory basis, the Company’s Named Executive Officer compensation for the fiscal year ended December 31, 2023.
3.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.
4.To approve the Amended and Restated Talos Energy Inc. 2021 Long Term Incentive Plan (the “Amended 2021 LTIP”).
5.To approve a Certificate of Amendment to the Company’s Second Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation (the “Exculpation Amendment”).
6.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益0.86美元,归母净利润1.01亿美元,同比去年增长-73.25%
|
| 2023-04-05 |
股东大会：
将于2023-05-09召开股东大会
会议内容 ▼▲
- 1.To elect to the Company’s Board of Directors the five Class II directors set forth in the accompanying Proxy Statement, each of whom will hold office until the 2025 Annual Meeting of Stockholders and until his or her successor is elected and qualified or until his or her earlier death, resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023.
3.To approve, on a non-binding advisory basis, the Company’s Named Executive Officer compensation for the fiscal year ended December 31, 2022.
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-01-10 |
股东大会：
将于2023-02-08召开股东大会
会议内容 ▼▲
- 1.A proposal (the “Share Issuance Proposal”) to approve, for purposes of complying with Section 312.03 of the NYSE Listed Company Manual, the potential issuance of shares of Talos common stock, par value $0.01 per share (“Talos Common Stock”), to the holders of EnVen Energy Corporation’s (“EnVen”) Class A common stock, par value $0.001 per share (“EnVen Common Stock”), in connection with the mergers and related transactions (the “Mergers”) pursuant to the terms of the Agreement and Plan of Merger, dated September 21, 2022 (the “Merger Agreement”).
2.To consider and vote upon each of the following proposals (collectively, the “A&R Charter Proposals”) to approve and adopt an amendment and restatement of the Second Amended and Restated Certificate of Incorporation of Talos (the “A&R Charter”) (in substantially the form attached to this proxy statement/consent solicitation statement/prospectus as Annex G). The A&R Charter Proposals are unrelated to the Mergers. The approval of the A&R Charter Proposals is not a condition to the consummation of the Mergers or the approval of the Share Issuance Proposal, and the consummation of the Mergers and approval of the Share Issuance Proposal are not conditions to the approval of the A&R Charter Proposals.(a)To declassify the Board of Directors of Talos (the “Talos Board”) from three classes to one class at the 2025 annual meeting of stockholders, with each Class I, Class II and Class III director being elected annually for a one-year term thereafter;(b)To provide that members of the Talos Board may be removed, with or without cause, by the affirmative vote of Talos stockholders holding at least a majority of the voting power of the outstanding shares of Talos Common Stock;(c)To provide that the Talos Amended and Restated Bylaws may be amended, altered or repealed by the affirmative vote of the holders of a majority of the voting power of Talos’s capital stock outstanding and entitled to vote thereon;(d)To clarify that, to the fullest extent permitted by and enforceable under applicable law, the exclusive forum for claims under the Securities Act shall be the federal district courts of the United States, and that such exclusive forum provision shall not apply to claims seeking to enforce any liability or duty created by the Exchange Act;(e)To make certain other administrative and clarifying changes to the A&R Charter that the Talos Board deems appropriate to effect the foregoing amendment proposals and the termination of the Stockholders’ Agreement as contemplated by the Talos Support Agreement.
3.A proposal (the “A&R Bylaws Proposal”) to approve and adopt, on a non-binding, advisory basis, an amendment and restatement of the Amended and Restated Bylaws of Talos (the “A&R Bylaws”) (in substantially the form attached to this proxy statement/consent solicitation statement/prospectus as Annex H). The A&R Bylaws Proposal is unrelated to the Mergers. The approval of the A&R Bylaws Proposal is not a condition to the consummation of the Mergers or the approval of the Share Issuance Proposal, and the consummation of the Mergers and approval of the Share Issuance Proposal are not conditions to the approval of the A&R Bylaws Proposal.
4.A proposal (the “Adjournment Proposal”) to approve the adjournment of the Special Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of any of the proposals.
|
| 2022-04-06 |
股东大会：
将于2022-05-11召开股东大会
会议内容 ▼▲
- 1.To elect to the Company’s Board of Directors the two Class I directors set forth in the accompanying Proxy Statement, each of whom will hold office until the 2025 Annual Meeting of Stockholders and until his or her successor is elected and qualified or until his or her earlier death, resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
3.To approve, on a non-binding advisory basis, the Company’s Named Executive Officer compensation for the fiscal year ended December 31, 2021.
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-06 |
股东大会：
将于2021-05-11召开股东大会
会议内容 ▼▲
- 1.To elect to the Company’s Board of Directors the four Class III directors set forth in the accompanying Proxy Statement, each of whom will hold office until the 2024 Annual Meeting of Stockholders and until his or her successor is elected and qualified or until his or her earlier death, resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021.
3.To approve, on a non-binding advisory basis, the Company’s Named Executive Officer compensation for the fiscal year ended December 31, 2020.
4.To approve the Company’s 2021 Long Term Incentive Plan in order to permit the delivery of shares of the Company’s common stock pursuant to awards granted thereunder.
5.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-04-08 |
股东大会：
将于2020-05-12召开股东大会
会议内容 ▼▲
- 1.To elect to the Company’s Board of Directors the three Class II directors set forth in the accompanying Proxy Statement, each of whom will hold office until the 2023 Annual Meeting of Stockholders and until his successor is elected and qualified or until his earlier death, resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020.
3.To approve, on a non-binding advisory basis, the Company’s Named Executive Officer compensation for the fiscal year ended December 31, 2019.
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2019-04-03 |
股东大会：
将于2019-05-06召开股东大会
会议内容 ▼▲
- 1.To elect to the Company’s Board of Directors the three Class I directors set forth in the accompanying Proxy Statement, each of whom will hold office until the 2022 Annual Meeting of Stockholders and until his or her successor is elected and qualified or until his or her earlier death, resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.
3.To approve, on a non-binding advisory basis, the Company’s Named Executive Officer compensation for the fiscal year ended December 31, 2018.
4.To vote on the approval, on a non-binding advisory basis, of the frequency of future advisory votes on the Company’s Named Executive Officer compensation.
5.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|